VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

被引：0
|
作者：
Graham, Christopher N. [1 ]
Mauskopf, Josephine [1 ]
Lawson, Anthony H. [2 ]
Ascher-Svanum, Haya [2 ]
Bruhn, David [2 ]
Watson, Peter R. [2 ]
机构：
[1] RTI Hlth Solut Res, Res Triangle Pk, NC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 2010年 / 117卷 / 2-3期
关键词：
D O I：
10.1016/j.schres.2010.02.722
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：398 / 399
页数：2
相关论文
共 50 条
  • [1] Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model: Comparing Two Antipsychotics in the Treatment of Schizophrenia
    Graham, Christopher N.
    Mauskopf, Josephine A.
    Lawson, Anthony H.
    Ascher-Svanum, Haya
    Bruhn, David
    VALUE IN HEALTH, 2012, 15 (01) : 55 - 64
  • [2] Industry-sponsored cost-effectiveness study of TAVI
    Littlejohn, Christopher
    Crilly, Michael A.
    HEART, 2012, 98 (16) : 1258 - 1258
  • [3] Cost-Effectiveness Model Comparing Olanzapine and Other Oral Atypical Antipsychotics in the Treatment of Schizophrenia in the United States
    Svanum, Ascher H.
    Furiak, N. M.
    Klein, R. W.
    Smolen, L. J.
    Lawson, A. H.
    Conley, R. R.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S3 - S4
  • [4] Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
    Furiak N.M.
    Ascher-Svanum H.
    Klein R.W.
    Smolen L.J.
    Lawson A.H.
    Conley R.R.
    Culler S.D.
    Cost Effectiveness and Resource Allocation, 7 (1)
  • [5] Cost-effectiveness of atypical antipsychotics in chronic schizophrenia
    Amin, S
    HOSPITAL MEDICINE, 1999, 60 (06): : 410 - 413
  • [6] Cost-effectiveness of treating schizophrenia with atypical antipsychotics
    Lewis, M
    Frangou, S
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 172 - 172
  • [7] Cost-effectiveness of treating schizophrenia with atypical antipsychotics
    Lewis, M
    Frangou, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 338 - 339
  • [8] Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
    Davies, Andrew
    Vardeva, Kawitha
    Loze, Jean-Yves
    L'Italien, Gilbert J.
    Sennfalt, Karin
    van Baardewijk, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3275 - 3285
  • [9] Cost-effectiveness of atypical antipsychotics in the CATIE schizophrenia trial
    Rosenheck, RA
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S32 - S32
  • [10] VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA
    Graham, C.
    Mauskopf, J.
    Lawson, A. H.
    Ascher-Svanum, H.
    Bruhn, D.
    Watson, P. R.
    VALUE IN HEALTH, 2010, 13 (03) : A113 - A113
12345